Ruminations

Behind the screen

The Wake-Up Protocol

—

by

Kyle
in

Chapter 9 of How to Live Forever

The fear is not death. Everyone dies and most people have made some peace with that. The fear is arriving at the end with the lights already off — body still running, brain already gone. A decade of accumulated confusions, lost threads, names that won’t come, thoughts that dissolve before they can be written down. Biological persistence without cognitive presence.

That is the version of aging most people accept as inevitable.

It is not inevitable. It is the result of not paying attention to the right variables for long enough.

This chapter is about paying attention. It is also, secondarily, about what happens when you do — which is that the cognitive output of your sixties can exceed the cognitive output of your thirties. Not despite the accumulation of years but because of what you chose to do with them.

The protocol described below has been refined over decades of reading the primary literature and iterating on results. It is what I do every morning. The flood of analytical writing that produced this book — the articles on AI supply chains and the Japanese carry trade and the physics of betavoltaic batteries and the institutional corruption of supplement research, written on the same days I am in the gym doing ten navy-style pull-ups and 550-pound leg presses at 66 — that output is the proof of concept.

The Problem the Protocol Solves

Neurological aging proceeds through several distinct but interacting mechanisms. Understanding them is prerequisite to addressing them, because a protocol designed without this understanding is just expensive guessing.

The first is acetylcholine depletion. Acetylcholine is the primary neurotransmitter of memory formation, sustained attention, and conscious learning. It is also the neurotransmitter that aging specifically and reliably degrades. The cholinergic neurons of the basal forebrain that project throughout the cortex and hippocampus are among the earliest casualties of normal aging, and their loss is the defining neurochemical feature of Alzheimer’s disease. The pharmaceutical response to this — acetylcholinesterase inhibitors like Aricept that slow the breakdown of whatever acetylcholine remains — is a maintenance drug for a declining system. The alternative is to supply the precursors for acetylcholine synthesis directly, maintaining production rather than rationing what’s left.

The second is structural atrophy. Neurons communicate through synaptic connections between axons and dendrites. These connections are not static. They extend, branch, and retract in response to use, stimulation, and nutritional availability. Neurodegeneration is in part a literal structural loss — the physical architecture of the brain simplifying, connections dropping away, dendritic trees pruning back. The discovery that specific compounds can stimulate Nerve Growth Factor and Brain-Derived Neurotrophic Factor — proteins that drive the growth and branching of neurons — means that this structural loss is not simply the inevitable arithmetic of time. It is a process that can be partially reversed and substantially slowed.

The third is mitochondrial failure. The brain constitutes roughly 2% of body weight and consumes approximately 20% of the body’s energy. It is the most metabolically demanding organ in the human body, and it runs entirely on mitochondria. As mitochondrial function declines with age — a process documented across every tissue type but particularly consequential in neurons, which cannot be replaced the way most cells can — the brain’s energy supply contracts. Cognitive fatigue, word-finding difficulty, attentional lapses, processing speed reduction: these are the symptoms of a brain running on reduced power.

The fourth is neuroinflammation. Chronic low-grade inflammation — the systemic inflammatory background that most aging people carry without awareness — penetrates the blood-brain barrier and activates the brain’s resident immune cells, microglia, which in an activated state produce cytokines that damage the very neurons they are nominally protecting. The connection between systemic inflammation and cognitive decline is now well-established. Managing inflammation throughout the body is therefore not separate from managing brain health. It is the same intervention.

The protocol addresses all four failure modes simultaneously, through independent mechanisms, beginning before breakfast.

The Coffee

A double-sized cup. Organic. Into it goes a blend: organic cacao, reishi, lion’s mane, cordyceps, organic coconut for its medium-chain triglycerides, and coconut sugar.

Each of these is doing something specific.

The cacao delivers flavanols that measurably improve cerebral blood flow and upregulate BDNF — the same growth factor that lion’s mane stimulates through a different pathway. Two independent BDNF triggers before the first hour of the day is over. The cocoa flavanol research is among the better-powered bodies of evidence in nutritional cognitive science: enough human trials, long enough duration, clear enough dose-response to be convincing.

The coconut oil provides medium-chain triglycerides that the liver rapidly converts to ketone bodies. The brain, unlike most tissues, can run on either glucose or ketones. In a state of mild glucose insufficiency — which the morning fast produces — ketones become an increasingly important substrate. MCTs are the fastest available ketone precursor, and a brain running partly on ketones during the morning working hours is a brain with an alternative fuel supply during the period when glucose metabolism is most constrained.

The medicinal mushrooms operate through mechanisms that the pharmaceutical industry cannot patent and therefore has little incentive to study at scale, despite a substantial literature on each.

Reishi modulates the immune system and reduces neuroinflammation — addressing the fourth failure mode — while supporting the deep sleep architecture that the brain requires for the overnight clearance of metabolic waste through the glymphatic system. Sleep quality and morning cognitive performance are not separate variables.

Lion’s mane stimulates the synthesis of Nerve Growth Factor in the brain. NGF promotes the survival, maintenance, and regrowth of cholinergic neurons — the exact neurons that aging destroys and that acetylcholine synthesis depends on. This is not a subtle effect reported in a single small study. It is a consistent finding across in vitro, animal, and human trials. Hericium erinaceus extracts promote neurite outgrowth — the literal extension of axons and dendrites to form new connections — in neural tissue. The structural atrophy failure mode is being addressed before the first sip is finished.

Cordyceps increases ATP production and oxygen utilization efficiency in mitochondria. The exercise chapter documented why this matters for physical performance. The same mitochondrial demand applies to the brain: a neuron that cannot produce adequate ATP cannot maintain its membrane potential, cannot fire reliably, cannot support the synaptic transmission that thinking requires.

The Tea

A pot of organic green tea, steeped with: rosemary, thyme, cloves, cardamom, bay leaf, cinnamon, ginger, and turmeric. All organic.

Green tea’s primary bioactive compound, EGCG, crosses the blood-brain barrier and operates there as an antioxidant, an anti-inflammatory agent, an inhibitor of the amyloid aggregation implicated in Alzheimer’s progression, and a BDNF upregulator. That is four independent neuroprotective mechanisms in a single compound. The epidemiological association between green tea consumption and reduced cognitive decline in aging Japanese populations is among the most consistent findings in the nutritional epidemiology of brain health.

The herbs are not decoration.

Rosemary contains rosmarinic acid and carnosic acid, both of which inhibit acetylcholinesterase — the enzyme that breaks down acetylcholine. This is the same mechanism as Aricept. It is also the mechanism by which ancient Mediterranean cultures empirically discovered, centuries before neurotransmitter chemistry existed, that rosemary was associated with memory. They were right. They did not know why. Now we do.

Turmeric’s curcumin crosses the blood-brain barrier and reduces neuroinflammation through NF-κB pathway inhibition. It also clears amyloid precursor proteins and upregulates BDNF. The bioavailability of curcumin is enhanced by piperine — the active compound in black pepper — but the quantities in the tea, combined with the fat in the morning’s coconut oil, provide meaningful absorption even without explicit piperine addition.

Cinnamon addresses a mechanism rarely discussed in cognitive health literature: brain insulin resistance. Neurons require insulin signaling for glucose uptake. As peripheral insulin resistance develops with age and diet, the brain increasingly struggles to access its primary fuel. Cinnamon contains compounds that sensitize insulin receptors and improve glucose metabolism, including in neural tissue. The connection between metabolic dysfunction and cognitive decline is now compelling enough that some researchers use the term “type 3 diabetes” to describe the insulin resistance component of Alzheimer’s pathology.

Ginger and cloves contribute the highest antioxidant densities of any commonly available spices, reducing the oxidative burden on neural tissue that high metabolic activity continuously generates.

The Stack

After the beverages, the supplement sequence.

Mem-Food provides lion’s mane again — the double dose ensuring meaningful NGF stimulation — alongside L-serine, a precursor to phosphatidylserine, a phospholipid that constitutes the neural cell membrane and is involved in acetylcholine synthesis, and blueberry juice powder whose anthocyanins independently support cerebral blood flow and reduce neuroinflammation.

Neuro-Mag is the most important non-obvious item in the protocol. Magnesium L-threonate is the only form of magnesium that reliably crosses the blood-brain barrier in meaningful quantities. The landmark 2010 paper in Neuron demonstrated that increasing brain magnesium through L-threonate supplementation increased synaptic density in aged rats and restored cognitive performance toward young-rat levels. The 2016 human trial — 44 adults aged 50 to 70, randomized, placebo-controlled — found markedly improved cognitive and executive function in twelve weeks. The mechanism is NMDA receptor modulation: magnesium regulates the calcium influx through NMDA receptors that underlies synaptic plasticity, the cellular basis of learning and memory. A brain depleted of magnesium — which most American brains are, magnesium being the most commonly insufficient mineral in the Western diet — is a brain with compromised synaptic plasticity. Neuro-Mag targets the problem at the synaptic level.

DMAE and Alpha GPC are both acetylcholine precursors, addressing the first failure mode directly. DMAE crosses the blood-brain barrier and converts to choline, then to acetylcholine. Alpha GPC is the most bioavailable choline source available, entering the synthesis pathway more efficiently than other choline forms. Together they are not redundant but complementary: different absorption kinetics, different tissue distribution, the same destination. Building the acetylcholine supply rather than rationing its remnants.

Gotu kola operates in the same structural domain as lion’s mane but through different mechanisms. Its primary active compounds — asiaticoside and asiatic acid — promote neurite outgrowth, dendritic branching, and BDNF production. Studies in aged rodents show both structural regeneration of neural processes and improvement in spatial memory and learning tasks. The traditional Ayurvedic reputation for gotu kola as a brain tonic — brahmi in Sanskrit, a word that also means consciousness — reflects millennia of empirical observation that preceded the mechanistic understanding by a long time.

Alpha-lipoic acid and acetyl-l-carnitine together constitute the mitochondrial rejuvenation stack documented by Bruce Ames at Berkeley. In aged rats, the combination restored mitochondrial function in brain tissue to near-young levels, as measured by oxygen consumption, membrane potential, and cognitive performance on maze tasks. ALA is unique among antioxidants in that it is both water and fat soluble, operating in both cellular compartments, and also regenerates other antioxidants — vitamin C, vitamin E, glutathione — that have been oxidized. ALCAR maintains the mitochondrial carnitine transport system essential for fatty acid oxidation in neural tissue. Together they address the energy failure that underlies so much of what aging does to the brain.

Ginkgo biloba has one of the longer research records of any cognitive supplement. Its mechanisms include increased cerebral blood flow through platelet-activating factor inhibition and smooth muscle relaxation, antioxidant protection through flavonoid content, and neuroprotective effects against glutamate excitotoxicity. The debate in the literature concerns magnitude of effect at standard doses, not whether the effect exists. More blood reaching more neurons, more efficiently, matters.

Cranberry proanthocyanidins have an emerging body of evidence for episodic memory improvement and increased functional brain connectivity on neuroimaging, operating through mechanisms that include cerebrovascular improvement, anti-inflammatory activity, and modulation of gut microbiome composition — the gut-brain axis being an increasingly documented pathway through which peripheral metabolic state influences central cognitive function.

Not Your Grandfather’s Smart Pills

Three newer products from the Life Extension Foundation represent the next generation of mind-enhancing supplements.

Cognitex® Elite is what a serious formulator does when they read the MIT literature instead of the marketing briefs.

Six actives, each addressing a distinct failure mode, none redundant with the others. The sageXtra™ extract — standardized to rosmarinic acid, which inhibits acetylcholinesterase exactly as Aricept does — adds a mechanism rosemary alone doesn’t provide: sage’s terpenoids directly modulate muscarinic and nicotinic acetylcholine receptors at the receptor level. You get AChE inhibition and receptor modulation simultaneously. The ashwagandha, as the patented Sensoril® form using both root and leaf, addresses the cortisol problem that most cognitive formulas ignore entirely: chronically elevated cortisol is specifically neurotoxic to hippocampal neurons, the structure memory depends on. Ashwagandha breaks that loop. Phosphatidylserine provides the structural phospholipid that constitutes 15% of the brain’s total phospholipid pool directly, without the conversion steps that L-serine requires. Vinpocetine dilates cerebral vasculature through PDE1 inhibition, improving blood flow and therefore oxygen and glucose delivery to every neuron downstream.

The ingredient that separates this formula from everything else on the shelf is Uridine-5′-Monophosphate. The Wurtman Laboratory at MIT spent years documenting UMP’s role in synapse formation: it converts to uridine, produces CDP-choline, and from there synthesizes both phosphatidylcholine for cell membranes and acetylcholine for neurotransmission. A completely independent back-door pathway to cholinergic support, arriving at the same destination as Alpha GPC and DMAE through entirely different chemistry. Almost no other consumer supplement contains it. Life Extension found the research, sourced the ingredient, and included it at a meaningful dose. That is the difference between a formulating company and a packaging company.

The subjective result is what the mechanism predicts: not stimulation, not a caffeine edge, but calm focused attention. The sage and ashwagandha quiet the noise floor — the background cortisol hum, the attentional static — while the cholinergic system runs clean underneath. The UMP is not producing an acute sensation. It is rebuilding the synaptic infrastructure through which everything else operates. One works today. The other is extending the substrate on which today’s effect runs.

It is deservedly expensive and worth it.

Quick Brain Nootropic & The Nootropic Question

The word “nootropic” was coined in 1972 by Romanian psychologist and chemist Corneliu Giurgea, who synthesized piracetam and needed a term for compounds that enhance learning and memory without stimulating or sedating. His original criteria were specific: the compound had to improve learning and memory, protect the brain under adverse conditions, enhance interhemispheric information transfer, increase resistance to cognitive disruption, and have essentially no toxicity or side effects.

By those criteria, most of what is currently marketed as “nootropics” doesn’t qualify. The category has been colonized by everything from simple caffeine to gray-market Soviet-era synthetic molecules — racetams, peptides, wakefulness agents — promoted in biohacking communities where regulatory inconvenience is treated as proof of efficacy and long-term safety data is considered an unnecessary luxury. Silicon Valley adopted the term and stripped it of Giurgea’s rigorous original meaning.

The legitimate concern about synthetic nootropics is not squeamishness. It is the basic risk-benefit calculation that any physicist applies to any intervention: the benefit has to be demonstrated and the risk has to be bounded. The racetam class — piracetam, aniracetam, oxiracetam, phenylpiracetam — has decades of Soviet and Eastern European research behind it, some of it credible, but also a regulatory gray zone, no FDA oversight, inconsistent manufacturing standards, and long-term safety profiles that remain incompletely characterized. Modafinil is a prescription pharmaceutical repurposed as a cognitive enhancer on the basis of studies in sleep-deprived populations — not the same as demonstrated benefit in healthy adults with adequate sleep. Microdosed LSD is a Schedule I substance whose cognitive enhancement claims rest almost entirely on self-reported user experience.

The botanical tradition has something the synthetic nootropic market largely lacks: centuries of empirical human use, followed by modern mechanistic and clinical validation. The compounds are familiar to human biology in a way that novel synthetics are not. The risk profile is bounded by history.

Quick Brain Nootropic is three botanical compounds, each with independent clinical evidence, combined in a once-daily formula that addresses neural processing speed, learning consolidation, and retention.

BaCognize® Ultra bacopa extract (150mg, 25% bacopa glycosides) is the most thoroughly researched natural nootropic that isn’t currently in the mainstream conversation. Bacopa monnieri — Brahmi in Ayurvedic medicine, where it has been used for cognitive enhancement for three thousand years — has accumulated a body of human RCT evidence that most pharmaceuticals cannot match. The bacosides modulate acetylcholinesterase, promote dendritic growth, reduce the rate of amyloid aggregation, and upregulate serotonin and dopamine synthesis. The finding that distinguishes bacopa from most cognitive supplements: it specifically reduces the rate of forgetting newly acquired information. Most nootropics improve acquisition. Bacopa improves retention. That is a different and more practically valuable mechanism for anyone whose concern is long-term cognitive integrity rather than short-term performance. The BaCognize® standardization to 25% bacopa glycosides is higher than most generic bacopa supplements and the proprietary extract carries its own human trial data.

Gotu kola extract (250mg, 10% asiaticosides) is a second daily dose reinforcing what the morning protocol already delivers. The standardized asiaticopside content ensures therapeutic-range delivery of the compounds responsible for BDNF production and neurite outgrowth. Two doses through different delivery vehicles — standalone supplement in the morning, Quick Brain at some point later — maintains the neurotrophic signaling across a broader window of the day.

Lutemax® 2020 marigold extract (110mg, 10% lutein, 2% meso-zeaxanthin and zeaxanthin) is the ingredient that earns the “nootropic” label most precisely. Lutein and zeaxanthin are best known for eye health — they concentrate heavily in the macula — but three independent year-long clinical studies established that they also accumulate in brain regions associated with cognitive function and, when supplemented, improve spatial memory, reasoning skills, cognitive flexibility, complex attention, and multitasking capacity by improving the brain’s ability to filter irrelevant information. The mechanism appears to involve neural plasticity modulation and antioxidant protection in neural membranes. The meso-zeaxanthin component in Lutemax® 2020 is not found in significant quantities in most food sources; it is almost exclusively available through marigold-derived supplementation or retinal tissue. This is the botanical side of nootropic science at its most interesting: a pigment compound originally identified for its role in protecting the retina, discovered to accumulate in and benefit the brain by mechanisms still being characterized.

The formula as a whole is what Giurgea meant: compounds that enhance cognitive function without stimulation, sedation, or meaningful toxicity, validated in clinical trials, derived from botanical sources with established safety profiles. It sits at the opposite end of the spectrum from gray-market racetam powders measured on kitchen scales.

Life Extension Foundation’s newest brain supplement is Ultra Memory & Recall. It contains only 2 ingredients:

Nutricog® is the more interesting of the two. It combines Terminalia chebula — one of the three fruits in Ayurveda’s foundational Triphala formula — with Boswellia serrata, standardized specifically to gallic acid, ellagic acid, and amyrins. Those standardization choices matter: gallic acid has documented acetylcholinesterase inhibitory activity, which puts it in the same mechanistic class as rosemary’s rosmarinic acid in your tea protocol — another AChE inhibitor arriving through a completely different botanical pathway. The clinical evidence is unusually clean: 100 healthy adults 40-65, randomized double-blind placebo-controlled, measuring actual cognitive outcomes. Ten more words recalled across five trials. Four more words on delayed recall after twenty minutes. Five more words on long-term episodic memory. And measured BDNF increase — adding another independent BDNF stimulation pathway on top of lion’s mane, gotu kola, and cocoa flavanols already in the morning stack.

cognitaven® — standardized green oat extract with a very specific active: 2″-O-arabinosyl-isovitexin, a C-glycosyl isoflavone with PDE4 inhibitory activity. PDE4 inhibition increases cyclic AMP in neurons, which drives neuroplasticity signaling. This is the same general mechanism as pharmaceutical ADHD treatments like rolipram — and a pathway not previously addressed by anything else in the protocol.

Boswellia was already mentioned for joint protection and comfort in my pre-workout stack. It now appears here for cognition, working through neuroinflammation reduction via leukotriene pathway inhibition. Same molecule showing up in two chapters addressing completely different systems. It should be no surprise that something the ancients found to be beneficial is only slowly being exposed by modern science.

Brain Fog

A fourth formula from Life Extension Foundation is called Brain Fog Relief.

Two ingredients, both standardized to 60% actives — which is the key detail. Most peppermint oil supplements aren’t standardized at all, meaning the active compound concentration is whatever the batch happens to contain. The standardization is what separates a therapeutic dose from an aromatic one.

Zynamite® mango leaf extract (300mg, 60% mangiferin) operates through a mechanism you won’t find in any other supplement in the protocol. Mangiferin is a C-glucosyl xanthone — an unusual polyphenol class — that modulates catecholamine neurotransmitters, specifically dopamine and norepinephrine, partly through MAO inhibition. Monoamine oxidase is the enzyme that breaks down these neurotransmitters; slow it down and their availability increases. This is the same general mechanism as a class of antidepressants — but botanical, non-pharmaceutical, and without the systemic side effects. It also specifically modulates histamine signaling in the brain, which is the connection most people miss. Histamine is a neurotransmitter of wakefulness and cognitive arousal — the reason antihistamines like Benadryl produce cognitive impairment and drowsiness as a primary side effect. Brain fog in many people is histamine dysregulation dressed as aging. Zynamite addresses it directly. The clinical studies show effects within 30 minutes — unusually fast for a botanical compound — making it experientially distinct from the structural supplements that work over weeks and months.

Peppermint essential oil (90mg, 60% monoterpenes) crosses the blood-brain barrier rapidly. Human studies show improvements in working memory, alertness, processing speed, and long-term memory consolidation. The monoterpenes modulate GABA receptors — calming without sedating — and have demonstrated AChE inhibitory activity, adding yet another independent pathway to the cholinergic support running through the rest of the morning protocol. The peppermint monoterpenes and the rosmarinic acid from rosemary in the tea act synergistically on overlapping pathways.

This is perhaps the most important supplement in the protocol psychologically — and the reason is precise. Every other cognitive supplement in the Wake-Up Protocol is doing structural work: rebuilding synaptic density, stimulating neurite outgrowth, maintaining acetylcholine synthesis, protecting mitochondrial membranes. That work is real and cumulative, but it is largely invisible subjectively. You do not feel your synaptic density increasing.

Brain fog is different. Everyone knows what it feels like — the inability to find the word, the thought that dissolves before it can be written down, the sense that the mind is running through resistance rather than cleanly. Most people have normalized it as aging. They have accepted it as the default state of a mind past fifty.

A supplement that specifically relieves that named experience — fast-acting, caffeine-free, without the crash that follows caffeine — provides immediate experiential confirmation that the protocol is working. It closes the gap between taking supplements for long-term brain health and feeling different today. That experiential feedback is what sustains compliance with everything else. The structural supplements maintain the instrument. Brain Fog Relief is the one that reminds you the instrument is still capable of playing.

It is the gateway supplement. The one that makes people believe the rest is real.

The Sublingual Trio

After the main stack, three more supplements — taken sublingually rather than swallowed. The delivery choice is deliberate in each case and not interchangeable with oral capsule forms.

B12 Elite provides 500mcg each of adenosylcobalamin and methylcobalamin — both active forms of B12, chosen specifically because they require no conversion before the body can use them. Standard cyanocobalamin supplements require two conversion steps before becoming biologically active; these arrive ready. The two forms do different things: methylcobalamin works in the central nervous system and is essential for homocysteine regulation — elevated homocysteine being one of the cleaner predictors of both cardiovascular and neurological decline. Adenosylcobalamin is active in the mitochondria, where it functions as a cofactor for succinyl-CoA synthesis in the energy metabolism cycle. Its more recently documented mechanism is inhibition of LRRK2 — Leucine-Rich Repeat Kinase 2 — an enzyme whose overactivity depletes dopamine availability in neural tissue. LRRK2 variants are strongly associated with Parkinson’s disease pathology. Adenosylcobalamin suppresses LRRK2 phosphorylation and preserves dopamine release.

The sublingual lozenge format bypasses the intrinsic factor requirement entirely. B12 absorption from food and oral supplements requires a glycoprotein called intrinsic factor produced by stomach cells — and intrinsic factor production declines with age and is absent in strict vegetarians who have reduced gastric acid production from decades of plant-based diet. Dissolving the lozenge under the tongue delivers B12 directly through the buccal mucosa into the bloodstream with no intrinsic factor required. For a forty-year vegetarian, this is not an optional refinement. It is the only reliable delivery mechanism.

Optimized Folate provides 5-methyltetrahydrofolate — 5-MTHF — the already-converted, biologically active form of folate. Standard folic acid supplements require conversion by the MTHFR enzyme before becoming usable. Approximately 40% of people carry an MTHFR gene variant that significantly impairs that conversion — meaning nearly half the population taking standard folic acid supplements is effectively folate-deficient despite supplementing. The 5-MTHF form bypasses the MTHFR step entirely. It enters the methylation cycle directly. B12 and folate are the two essential partners in the methylation cycle — they recycle homocysteine back to methionine, support DNA synthesis and repair, regulate neurotransmitter production, and maintain the epigenetic methylation patterns that gene expression depends on. Taking them sublingually together means both arrive in circulation simultaneously, which is how the cycle actually runs.

Korean Red Ginseng (500mg) is the adaptogen of the three — Panax ginseng steam-processed into its red form, which creates ginsenoside profiles not present in white or American ginseng. The steam processing transforms Rg1 and Rb1 ginsenosides and generates Rg3, a compound with neuroprotective, anti-inflammatory, and cognitive properties unique to the red form. Rg1 upregulates BDNF and stimulates neurogenesis in the hippocampus. Rb1 reduces mental and physical fatigue and has shown anti-amyloid properties. The combination modulates the HPA axis — the true definition of an adaptogen: not stimulating, not sedating, but normalizing the stress response system toward baseline. Korean red ginseng also supports nitric oxide production, improving vascular tone and cerebral blood flow, and has documented effects on both testosterone support and acetylcholine and dopamine systems — connecting it simultaneously to the hormone chapter, the vascular chapter, and the cholinergic support running throughout the morning protocol.

The sublingual ginseng absorption is felt differently from swallowing a capsule. The ginsenosides are bitter enough to register clearly through the buccal mucosa, and the absorption begins before the lozenge dissolves. This is not incidental — bitter taste receptor stimulation in the oral cavity triggers digestive and metabolic preparatory responses that enhance downstream absorption of everything that follows.

Three supplements. One methylation pair working in biochemical concert. One adaptogen threading through four separate systems simultaneously. All three delivered sublingually for maximum bioavailability through the fastest available absorption route.

The morning protocol is now complete.

The Double Meaning

The Wake-Up Protocol is named for what it does each morning. But it is also the larger project of which the morning routine is a single expression: the refusal to accept neurological decline as scheduled, the decision to intervene in the mechanisms of cognitive aging with the same systematic attention applied to every other domain in this book.

That the articles in this book’s bibliography include pieces written in the same sessions as this chapter — analyses of AI supply chain constraints, carry trade dynamics, betavoltaic battery physics, the institutional suppression of supplement research — is not incidental to the argument. It is the argument. The cognitive output is the measurement.

A standard physician looking at my supplement list would see expense and complexity and perhaps quackery. I see a systematic response to four documented failure modes, each addressed through independent mechanisms that together produce a cognitive environment where the writing flows and the connections between disparate fields become visible.

No one can tell me the protocol doesn’t work. The proof is in the pudding.

Chapter 10: The Annual Increment — What Has Come Out Almost Every Year for Thirty Years

The Full Protocol

A double-sized cup of Organic Coffee with my cocoa blend (below)

A pot of Organic Green Tea with my life extension blend (below)

The Morning Coffee Blend

Standard organic coffee is the base. Into it goes:

  • Organic cacao 1 cup — flavanols for cerebral blood flow and BDNF
  • Reishi mushroom 1/4 cup — neuroinflammation reduction, sleep architecture support
  • Lion’s Mane mushroom 1/4 cup— Nerve Growth Factor stimulation, neurite outgrowth
  • Cordyceps mushroom 1/4 cup — mitochondrial ATP production, oxygen utilization
  • Organic Coconut shreds 1/2 cup — medium-chain triglycerides converted rapidly to ketones, alternative brain fuel during the fasting window
  • Coconut sugar 1/4 cup — not too much!

I combine these in a coffee grinder and store in a sealed container. I add about a tablespoon of the blend to a double-sized cup of coffee. The cocoa & mushroom powders blend cleanly into hot coffee without being obvious – just a richer, deeper flavor. The coconut provides enough fat to enhance absorption of the fat-soluble active compounds.

The Herb Tea — Thirty Years in Development

Began with rosemary and cloves in the early 1990s — the two highest-antioxidant herbs in the common Western spice rack, both with documented cognitive effects. Each subsequent ingredient was added as its research profile became convincing. The base is organic green tea, which delivers EGCG — antioxidant, anti-inflammatory, BDNF-upregulating, and amyloid-inhibiting — across the full pot. I use 4 tea bags per pot.

The herb blend, all organic:

  • Rosemary 1/3 cup — rosmarinic acid: AChE inhibitor, same mechanism as Aricept
  • Thyme 1 tbsp— complementary flavonoids, antioxidant, antimicrobial
  • Cloves 1/4 cup — highest ORAC value of any common spice; eugenol: antioxidant, anti-inflammatory
  • Cardamom 1 tbsp — antioxidant, anti-inflammatory, and — per a 2026 RCT — cognitive effects comparable to caffeine, synergistically enhanced by it
  • 1 Bay leaf — antioxidant, insulin sensitizing
    I grind the above all at once in a coffee grinder
  • Licorice root 1/2 cup – anti-inflammatory, adaptogen, natural sweetener, modulates glucose metabolism
  • Cinnamon 1/3 cup — insulin receptor sensitization, glucose management, brain insulin resistance
  • Ginger 1/3 cup — anti-inflammatory, glycemic support, cognitive protection
  • Turmeric 1/3 cup — curcumin: NF-κB neuroinflammation reduction, amyloid clearance, BDNF

I buy Licorice root in bulk as chopped up pieces. These should be ground before adding. I also buy the cinnamon, ginger, and turmeric in bulk powder form. All mixed up ahead of time, I just add a heaping tablespoon of the blend along with the tea bags after the water has boiled and the pot removed from heat.

This is simultaneously a cognitive support protocol, an antioxidant delivery system, and a glycemic management intervention. It took thirty years to assemble. It takes ten minutes to make.

Interesting note on Cardamom: I added it to the blend years ago largely because of its reputation for enhancing creativity. Of course, being another antioxidant and anti-inflammatory spice helped that decision. A 2026 randomized double-blind placebo-controlled human trial then established that cardamom extract improves attention, working memory, and processing speed at levels comparable to caffeine, with more sustained effects when caffeine is present. My blend was already capturing this synergy before the paper existed to name it. This is not an unusual occurrence in a protocol assembled over thirty years from primary literature. The mechanism catches up to the observation. It always does.

Selected References

Slutsky I, et al. “Enhancement of learning and memory by elevating brain magnesium.” Neuron 65(2):165-77. 2010.

Liu G, et al. “Efficacy and safety of MMFS-01, a synapse density enhancer, for treating cognitive impairment in older adults.” Journal of Alzheimer’s Disease 49(4):971-90. 2016.

Mori K, et al. “Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment.” Phytotherapy Research 23(3):367-72. 2009.

Ames BN, Liu J. “Delaying the mitochondrial decay of aging with acetylcarnitine.” Annals of the New York Academy of Sciences 1033:108-16. 2004.

Soumyanath A, et al. “Centella asiatica accelerates nerve regeneration upon oral administration and contains multiple active fractions increasing neurite elongation in vitro.” Journal of Pharmacy and Pharmacology 57(9):1221-9. 2005.

Mars M, et al. “Cocoa flavanol intake improves hippocampal-dependent memory in healthy humans.” Scientific Reports 10:19160. 2020.

de Oliveira IJ, et al. “Effects of oral vitamin C supplementation on anxiety in students.” Pakistan Journal of Biological Sciences 18(1):11-18. 2015. (Rosemary AChE inhibition studies referenced through 2018 Therapeutic Advances in Psychopharmacology series.)

Lipton SA. “Paradigm shift in neuroprotection by NMDA receptor blockade.” Nature Reviews Drug Discovery 5(2):160-70. 2006. (Magnesium NMDA modulation mechanism.)

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *